Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-9-1
|
pubmed:abstractText |
Glucose-6-phosphate dehydrogenase is inactivated slowly by reaction with sugars (glycation), a process thought to be important in the development of diabetic complications. A major protein from the ocular lens, alpha-crystallin. which exhibits some chaperone-like properties, protects against this inactivation. The well-known molecular chaperone GroEL (chaperonin 60 from Escherichia coli) also protects. On a molar basis, alpha-crystallin is better than GroEL at protecting against glycation-induced inactivation of glucose-6-phosphate dehydrogenase. The relative amounts of enzyme/chaperone indicate that each molecule of alpha-crystallin binds two molecules of the damaged enzyme. This supports the view that alpha-crystallin has a chaperone-like structure as well as a chaperone-like function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chaperonin 60,
http://linkedlifedata.com/resource/pubmed/chemical/Crystallins,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Glucosephosphate Dehydrogenase,
http://linkedlifedata.com/resource/pubmed/chemical/Molecular Chaperones
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0014-2956
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
231
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
181-5
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading | |
pubmed:year |
1995
|
pubmed:articleTitle |
Molecular chaperones protect against glycation-induced inactivation of glucose-6-phosphate dehydrogenase.
|
pubmed:affiliation |
Nuffield Laboratory of Ophthalmology, University of Oxford, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|